Skip to main content
Open
Question
Forecasts
Track record
Unknowns
How it works
Sources
FAQ
Menu
← Evidence map
Article
Cancer discovery
2014
BCR-ABL1 compound mutations drive ponatinib resistance.
PubMed ↗
Publisher ↗
No numbers read from the abstract.
2 papers cite it
2014
2015
2016
2017
2018
2019
2020
2021
2022
this paper
cites it
BCR-ABL1 compound mutations drive ponatinib resistance. | OpenQuestion